rs10927011

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006642.5(SDCCAG8):​c.1725G>A​(p.Glu575Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.495 in 1,612,870 control chromosomes in the GnomAD database, including 205,353 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.42 ( 15777 hom., cov: 33)
Exomes 𝑓: 0.50 ( 189576 hom. )

Consequence

SDCCAG8
NM_006642.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 1.55

Publications

23 publications found
Variant links:
Genes affected
SDCCAG8 (HGNC:10671): (SHH signaling and ciliogenesis regulator SDCCAG8) This gene encodes a centrosome associated protein. This protein may be involved in organizing the centrosome during interphase and mitosis. Mutations in this gene are associated with retinal-renal ciliopathy. [provided by RefSeq, Oct 2010]
SDCCAG8 Gene-Disease associations (from GenCC):
  • Senior-Loken syndrome 7
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • Bardet-Biedl syndrome 16
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Senior-Loken syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 1-243415810-G-A is Benign according to our data. Variant chr1-243415810-G-A is described in ClinVar as Benign. ClinVar VariationId is 260009.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.55 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.758 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SDCCAG8NM_006642.5 linkc.1725G>A p.Glu575Glu synonymous_variant Exon 14 of 18 ENST00000366541.8 NP_006633.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SDCCAG8ENST00000366541.8 linkc.1725G>A p.Glu575Glu synonymous_variant Exon 14 of 18 1 NM_006642.5 ENSP00000355499.3
SDCCAG8ENST00000435549.1 linkc.957-10617G>A intron_variant Intron 8 of 10 1 ENSP00000410200.1
SDCCAG8ENST00000493334.1 linkn.692G>A non_coding_transcript_exon_variant Exon 5 of 5 5

Frequencies

GnomAD3 genomes
AF:
0.421
AC:
63995
AN:
151982
Hom.:
15777
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.159
Gnomad AMI
AF:
0.426
Gnomad AMR
AF:
0.547
Gnomad ASJ
AF:
0.510
Gnomad EAS
AF:
0.778
Gnomad SAS
AF:
0.416
Gnomad FIN
AF:
0.522
Gnomad MID
AF:
0.522
Gnomad NFE
AF:
0.503
Gnomad OTH
AF:
0.461
GnomAD2 exomes
AF:
0.500
AC:
124877
AN:
249974
AF XY:
0.497
show subpopulations
Gnomad AFR exome
AF:
0.144
Gnomad AMR exome
AF:
0.584
Gnomad ASJ exome
AF:
0.512
Gnomad EAS exome
AF:
0.768
Gnomad FIN exome
AF:
0.515
Gnomad NFE exome
AF:
0.501
Gnomad OTH exome
AF:
0.501
GnomAD4 exome
AF:
0.503
AC:
734612
AN:
1460770
Hom.:
189576
Cov.:
51
AF XY:
0.500
AC XY:
363494
AN XY:
726648
show subpopulations
African (AFR)
AF:
0.137
AC:
4567
AN:
33434
American (AMR)
AF:
0.576
AC:
25657
AN:
44560
Ashkenazi Jewish (ASJ)
AF:
0.515
AC:
13444
AN:
26106
East Asian (EAS)
AF:
0.774
AC:
30719
AN:
39686
South Asian (SAS)
AF:
0.420
AC:
36199
AN:
86232
European-Finnish (FIN)
AF:
0.507
AC:
27070
AN:
53380
Middle Eastern (MID)
AF:
0.505
AC:
2882
AN:
5710
European-Non Finnish (NFE)
AF:
0.507
AC:
563580
AN:
1111328
Other (OTH)
AF:
0.505
AC:
30494
AN:
60334
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
19336
38672
58009
77345
96681
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16298
32596
48894
65192
81490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.421
AC:
64005
AN:
152100
Hom.:
15777
Cov.:
33
AF XY:
0.425
AC XY:
31574
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.159
AC:
6582
AN:
41498
American (AMR)
AF:
0.548
AC:
8371
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.510
AC:
1771
AN:
3470
East Asian (EAS)
AF:
0.778
AC:
4024
AN:
5172
South Asian (SAS)
AF:
0.415
AC:
2002
AN:
4828
European-Finnish (FIN)
AF:
0.522
AC:
5518
AN:
10572
Middle Eastern (MID)
AF:
0.520
AC:
153
AN:
294
European-Non Finnish (NFE)
AF:
0.503
AC:
34215
AN:
67962
Other (OTH)
AF:
0.465
AC:
982
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1732
3464
5195
6927
8659
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
588
1176
1764
2352
2940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.479
Hom.:
74779
Bravo
AF:
0.411
Asia WGS
AF:
0.567
AC:
1973
AN:
3478
EpiCase
AF:
0.498
EpiControl
AF:
0.502

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Senior-Loken syndrome 7 Benign:3
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Bardet-Biedl syndrome 16 Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Senior-Loken syndrome 7;C3889474:Bardet-Biedl syndrome 16 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
4.4
DANN
Benign
0.42
PhyloP100
1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10927011; hg19: chr1-243579112; COSMIC: COSV100653902; COSMIC: COSV100653902; API